Pandorum Technologies

About

Pandorum Technologies is a biotechnology company based in Bengaluru, India, founded in 2011. The company specializes in tissue engineering and regenerative medicine, focusing on developing functional human tissues and cell-free therapies for conditions affecting the cornea, liver, and lungs. With operations and R&D labs in the US, Pandorum combines expertise in life sciences, engineering, and clinical applications to create proprietary platforms for therapeutic products. One of its flagship products is Kuragenx, a liquid cornea treatment that promotes new cornea growth. The company also develops 3D human liver organoids for drug discovery and lung regeneration therapies targeting post-trauma damage. Pandorum's platforms support medical research and therapeutic applications, including bio-printed tissues and exosome-based therapies. The company is advancing toward clinical stages, with a first-in-human clinical study for Kuragenx planned for 2024.